None listed
Conditions
Interventions
Drug : 0.3 mg of Nasea is mixed with physiological saline (0.9%
sodium chloride) and injected intravenously with 5 cc. In order to achieve a double blindness, inject a syringe of the same shape and capacity as the control saline. Ramosetron is a transparent compon
Sponsors
Chonnam National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients between 18 and 80 years of age who meet the following criteria: Disease: The definition of fibromyalgia is based on the criteria published by the American Society of Rheumatology (ACR) in 2010, and the patients who meet the following criteria are eligible. 1) The patients who meet the 2010 ACR criteria for fibromyalgia 2) No response after 4 weeks of standard medication 3) Pain VAS 40 and FIQ score of 45 or more 4) The patients who are fully informed about the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients complaining of pain due to other rheumatic diseases. 2) The patients who had a certain diseases such as uncontrolled tumors 3) If patients have uncontrolled illness or psychiatric illness 4) If patients have a history of drug addiction 5) Patients who are pregnant or expect to become pregnant 6) If there is a previous history of study drug use before 30 days 7) Patients with severe complications due to drug allergy are excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain VAS | — |
Secondary
| Measure | Time frame |
|---|---|
| Fibromyalgia Impact Questionnaire (FIQ) | — |
Countries
Korea, Republic of
Contacts
Public ContactDongjin Park
Chonnam National University Hospital
Outcome results
None listed